Jun.17 — Pfizer Inc. will buy Array BioPharma Inc. for $10.6 billion to gain its promising new medicines for cancer, which could end or limit the use of punishing chemotherapy for some patients. Bloomberg’s Cynthia Koons reports on „Bloomberg Markets.“
source
Why Pfizer Is Buying Array BioPharma for $10.6 Billion
